277 related articles for article (PubMed ID: 24430001)
1. The KEEPS-Cognitive and Affective Study: baseline associations between vascular risk factors and cognition.
Wharton W; Gleason CE; Dowling NM; Carlsson CM; Brinton EA; Santoro MN; Neal-Perry G; Taylor H; Naftolin F; Lobo RA; Merriam G; Manson JE; Cedars MI; Miller VM; Black DM; Budoff M; Hodis HN; Harman SM; Asthana S
J Alzheimers Dis; 2014; 40(2):331-41. PubMed ID: 24430001
[TBL] [Abstract][Full Text] [Related]
2. Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study.
Gleason CE; Dowling NM; Wharton W; Manson JE; Miller VM; Atwood CS; Brinton EA; Cedars MI; Lobo RA; Merriam GR; Neal-Perry G; Santoro NF; Taylor HS; Black DM; Budoff MJ; Hodis HN; Naftolin F; Harman SM; Asthana S
PLoS Med; 2015 Jun; 12(6):e1001833; discussion e1001833. PubMed ID: 26035291
[TBL] [Abstract][Full Text] [Related]
3. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS).
Taylor HS; Tal A; Pal L; Li F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Du W; Hodis HN; Lobo RA; Manson JE; Merriam GR; Miller VM; Naftolin F; Neal-Perry G; Santoro NF; Harman SM
JAMA Intern Med; 2017 Oct; 177(10):1471-1479. PubMed ID: 28846767
[TBL] [Abstract][Full Text] [Related]
4. Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition.
Kantarci K; Lowe VJ; Lesnick TG; Tosakulwong N; Bailey KR; Fields JA; Shuster LT; Zuk SM; Senjem ML; Mielke MM; Gleason C; Jack CR; Rocca WA; Miller VM
J Alzheimers Dis; 2016 May; 53(2):547-56. PubMed ID: 27163830
[TBL] [Abstract][Full Text] [Related]
5. Rationale and design of the Kronos Early Estrogen Prevention Study (KEEPS) and the KEEPS Cognitive and Affective sub study (KEEPS Cog).
Wharton W; Gleason CE; Miller VM; Asthana S
Brain Res; 2013 Jun; 1514():12-7. PubMed ID: 23603409
[TBL] [Abstract][Full Text] [Related]
6. Lessons from KEEPS: the Kronos Early Estrogen Prevention Study.
Miller VM; Taylor HS; Naftolin F; Manson JE; Gleason CE; Brinton EA; Kling JM; Cedars MI; Dowling NM; Kantarci K; Harman SM
Climacteric; 2021 Apr; 24(2):139-145. PubMed ID: 32880220
[TBL] [Abstract][Full Text] [Related]
7. Impact of menopausal hormone formulations on pituitary-ovarian regulatory feedback.
Kling JM; Dowling NM; Bimonte-Nelson HA; Gleason CE; Kantarci K; Manson JE; Taylor HS; Brinton EA; Lobo RA; Cedars MI; Pal L; Neal-Perry G; Naftolin F; Harman SM; Miller VM
Am J Physiol Regul Integr Comp Physiol; 2019 Dec; 317(6):R912-R920. PubMed ID: 31663769
[TBL] [Abstract][Full Text] [Related]
8. Sleep quality and cortical amyloid-β deposition in postmenopausal women of the Kronos early estrogen prevention study.
Zeydan B; Lowe VJ; Tosakulwong N; Lesnick TG; Senjem ML; Jack CR; Fields JA; James TT; Gleason CE; Dowling NM; Miller VM; Kantarci K
Neuroreport; 2021 Mar; 32(4):326-331. PubMed ID: 33470769
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of hormone therapy on serotonin, vascular function and mood in the KEEPS.
Raz L; Hunter LV; Dowling NM; Wharton W; Gleason CE; Jayachandran M; Anderson L; Asthana S; Miller VM
Climacteric; 2016; 19(1):49-59. PubMed ID: 26652904
[TBL] [Abstract][Full Text] [Related]
10. Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study.
Asthana S; Craft S; Baker LD; Raskind MA; Birnbaum RS; Lofgreen CP; Veith RC; Plymate SR
Psychoneuroendocrinology; 1999 Aug; 24(6):657-77. PubMed ID: 10399774
[TBL] [Abstract][Full Text] [Related]
11. Effects of hormone therapy on brain structure: A randomized controlled trial.
Kantarci K; Tosakulwong N; Lesnick TG; Zuk SM; Gunter JL; Gleason CE; Wharton W; Dowling NM; Vemuri P; Senjem ML; Shuster LT; Bailey KR; Rocca WA; Jack CR; Asthana S; Miller VM
Neurology; 2016 Aug; 87(9):887-96. PubMed ID: 27473135
[TBL] [Abstract][Full Text] [Related]
12. Associations between pituitary-ovarian hormones and cognition in recently menopausal women independent of type of hormone therapy.
Kling JM; Dowling NM; Bimonte-Nelson H; Gleason CE; Kantarci K; Stonnington CM; Harman SM; Naftolin F; Pal L; Cedars M; Manson JE; James TT; Brinton EA; Miller VM
Maturitas; 2023 Jan; 167():113-122. PubMed ID: 36395695
[TBL] [Abstract][Full Text] [Related]
13. Differences in verbal memory performance in postmenopausal women receiving hormone therapy: 17β-estradiol versus conjugated equine estrogens.
Wroolie TE; Kenna HA; Williams KE; Powers BN; Holcomb M; Khaylis A; Rasgon NL
Am J Geriatr Psychiatry; 2011 Sep; 19(9):792-802. PubMed ID: 21873835
[TBL] [Abstract][Full Text] [Related]
14. Cardiometabolic outcomes in Kronos Early Estrogen Prevention Study continuation: 14-year follow-up of a hormone therapy trial.
Kantarci K; Tosakulwong N; Lesnick TG; Kara F; Kendall-Thomas J; Kapoor E; Fields JA; James TT; Lobo RA; Manson JE; Pal L; Hammers DB; Malek-Ahmadi M; Cedars MI; Naftolin FN; Santoro N; Miller VM; Harman SM; Dowling NM; Gleason CE
Menopause; 2024 Jan; 31(1):10-17. PubMed ID: 37989141
[TBL] [Abstract][Full Text] [Related]
15. Effects of oral versus transdermal menopausal hormone treatments on self-reported sleep domains and their association with vasomotor symptoms in recently menopausal women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS).
Cintron D; Lahr BD; Bailey KR; Santoro N; Lloyd R; Manson JE; Neal-Perry G; Pal L; Taylor HS; Wharton W; Naftolin F; Harman SM; Miller VM
Menopause; 2018 Feb; 25(2):145-153. PubMed ID: 28832429
[TBL] [Abstract][Full Text] [Related]
16. Heart fat and carotid artery atherosclerosis progression in recently menopausal women: impact of menopausal hormone therapy: The KEEPS trial.
El Khoudary SR; Venugopal V; Manson JE; Brooks MM; Santoro N; Black DM; Harman M; Naftolin F; Hodis HN; Brinton EA; Miller VM; Taylor HS; Budoff MJ
Menopause; 2020 Mar; 27(3):255-262. PubMed ID: 32015261
[TBL] [Abstract][Full Text] [Related]
17. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
Araújo DA; Farias ML; Andrade AT
Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
[TBL] [Abstract][Full Text] [Related]
18. Oral conjugated equine estrogen increases plasma von Willebrand factor in postmenopausal women.
Rabbani LE; Seminario NA; Sciacca RR; Chen HJ; Giardina EG
J Am Coll Cardiol; 2002 Dec; 40(11):1991-9. PubMed ID: 12475460
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study.
Santoro N; Allshouse A; Neal-Perry G; Pal L; Lobo RA; Naftolin F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Dowling NM; Dunn M; Gleason CE; Hodis HN; Isaac B; Magnani M; Manson JE; Miller VM; Taylor HS; Wharton W; Wolff E; Zepeda V; Harman SM
Menopause; 2017 Mar; 24(3):238-246. PubMed ID: 27779568
[TBL] [Abstract][Full Text] [Related]
20. Transdermal versus oral estrogen therapy in postmenopausal smokers: hemodynamic and endothelial effects.
Girdler SS; Hinderliter AL; Wells EC; Sherwood A; Grewen KM; Light KC
Obstet Gynecol; 2004 Jan; 103(1):169-80. PubMed ID: 14704262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
